• Home
  • EMCrit
  • PulmCrit
  • IBCC
  • ODR
  • About
    • About EMCrit
    • PulmCrit – The Full Story
    • EMCrit FAQ
    • Subscribe to the Newsletter
  • Contact
  • Join
    • Why Should I Become a Member?
    • Questions Before Joining (FAQ)
    • Join Now!

EMCrit Project

Online Medical Education on Emergency Department (ED) Critical Care, Trauma, and Resuscitation

  • EMCrit Archives
  • EDICUs
You are here: Home / Archives for Josh Farkas

PulmCrit – Want to help stop COVID? Be quiet.

December 1, 2020 by Josh Farkas 3 Comments

The closed mouth catches no flies Benjamin Franklin, Poor Richard’s Almanac, 1742 We’re hopefully nearing the end of the COVID pandemic, with vaccines coming soon.  Unfortunately, vaccines won’t be able to bail us out this winter.  Neither will fancy designer pharmaceuticals.  The main interventions necessary to keep us safe for now are basic public health […]

PulmCrit – I’m so confused about bamlanivimab

November 30, 2020 by Josh Farkas 12 Comments

2020 has been a weird year by any standard.  So, I shouldn’t be surprised that the bamlanivimab story is so weird.  But still.  Anyhow, if you’re ready to go down the rabbit hole, here we go… derivation and early testing The story begins with Eli Lilly designing a monoclonal anti-spike antibody to neutralize COVID-19. The […]

PulmCrit – Oscar awards for the best COVID prognostic models

November 28, 2020 by Josh Farkas 5 Comments

We are continually tasked with triaging COVID patients, a situation which will become more complex as the numbers continue to rise.  This involves making educated guesses about which patients are most likely to deteriorate, and which patients may benefit most from critical care.  That’s enormously difficult. At this point, we’re quite familiar with individual risk […]

PulmCrit – Heparin resistance in COVID & implications for DVT prophylaxis

November 24, 2020 by Josh Farkas 4 Comments

background:  what is heparin resistance? Heparin works by binding to antithrombin III and thereby activating antithrombin III, an endogenous anticoagulant which inhibits clotting factors (especially Xa).  Heparin + Anti-thrombin III → [Heparin-Antithrombin-III complex] → Inhibition of Xa activity Heparin resistance refers to situations where unusually large doses of heparin are required to achieve anticoagulation.  This […]

PulmCrit: Why the DAMASK trial is a futile diversion – The limitations of RCTs

November 23, 2020 by Josh Farkas 3 Comments

When I saw the infographic for the DAMASK trial (below), it was immediately clear to me that the trial was inconclusive (not positive, not negative – inconclusive). According to this study, masks might be totally worthless. Or masks might reduce infection by ~40%. This is an inconclusive study. It yields no answer.

IBCC chapter & cast – Toxic Shock Syndrome

November 16, 2020 by Josh Farkas 1 Comment

Not all septic shock is created equal.  Toxic shock syndrome is one of the most fulminant and dangerous forms of septic shock.  It is one of the few infectious diseases capable of rapidly killing previously healthy young people.  Most importantly, toxic shock syndrome requires targeted therapy – it often fails to respond to conventional therapy […]

IBCC chapter & cast – Ventilator Associated Pneumonia (VAP)

November 9, 2020 by Josh Farkas 9 Comments

VAP is a perennial riddle in the intensive care unit.  There are numerous murky diagnostic tests, but no single gold-standard diagnostic test.  Consequently, we are usually left wondering whether or not the patient truly has a VAP.  This makes VAP an unsatisfying diagnosis, as we are continually walking a blurred line between undertreatment and overtreatment. […]

IBCC chapter & cast – Sedation for the intubated patient

November 2, 2020 by Josh Farkas 7 Comments

Sedation is one of the details of ICU care which seems unimportant…  until it’s not.  Over the past decade we’ve seen a burgeoning repertoire of agents used for sedation and agitated delirium.  Unfortunately, the number of medications has out-stripped available Level-I evidence regarding how exactly to use them.  This chapter attempts to create a framework […]

IBCC chapter & cast – Lithium intoxication

October 26, 2020 by Josh Farkas 1 Comment

Lithium intoxication is a tricky issue, with a variety of different forms which may call for different therapies (acute, chronic, or acute-on-chronic intoxication).  To further complicate matters, the pathophysiology of lithium toxicity isn’t understood – particularly, how lithium levels might relate to chronic neurotoxicity (SILENT syndrome).  Finally, as is often the case in toxicology, there […]

IBCC chapter & cast – Stress hyperglycemia in the ICU

October 19, 2020 by Josh Farkas 2 Comments

Glycemic control in the ICU is a topic of perpetual controversy.  We’ve come full circle in the past 20 years – beginning with permissive hyperglycemia, then moving to tight control, and finally now moving back to permissive hyperglycemia.  The final answer remains unknown, but in the interim this chapter attempts to muddle through available evidence. […]

IBCC chapter & cast – Wernicke encephalopathy

October 14, 2020 by Josh Farkas 1 Comment

Wernicke encephalopathy is important because it’s surprisingly common, potentially debilitating, and fully treatable.  Some patients may present to the hospital due to Wernicke encephalopathy, while many others may develop this while in the ICU as an iatrogenic complication of criical care. The IBCC chapter is located 👉 here. The podcast & comments are below. Follow […]

IBCC chapter & cast – Valproic Acid Intoxication

October 5, 2020 by Josh Farkas 1 Comment

Valproic acid poisoning is fortunately uncommon.  However, this is a potentially lethal and rather complex intoxication.  Management spans the gamut from decontamination and dialysis, to various metabolic manipulations.  With an aggressive and organized approach, most patients will do extremely well. The IBCC chapter is located 👉 here. The podcast & comments are below. Follow us […]

IBCC chapter & cast – BRASH syndrome

September 28, 2020 by Josh Farkas 8 Comments

BRASH syndrome refers to a vicious spiral wherein hyperkalemia and AV nodal blockers synergize to cause progressive renal failure, bradycardia, shock, and hyperkalemia.  The treatment is largely a combination of standard therapies for hyperkalemia and bradycardia.  Recognizing this syndrome as a specific entity may help us more fully understand our patients’ physiology, facilitating a more […]

IBCC chapter & cast – Hemophagocytic LymphoHistiocytosis (HLH)

September 21, 2020 by Josh Farkas 2 Comments

Intensivists have long been struggling with the enigma of hemophagocytic lymphohistiocytosis (HLH).  For example, this post from 2016 explores the challenge of dissecting HLH away from septic shock.  The COVID pandemic has drawn some attention to the topic, although it’s not clear to what extent COVID might truly reflect HLH.  This chapter attempts to lay […]

IBCC chapter & cast – Gastrointestinal hypomotility in critical care

September 14, 2020 by Josh Farkas 4 Comments

Critical illness leads to a variety of gastrointestinal motility problems (largely due to the constellation of immobility, medications, and metabolic abnormalities).  Although these topics don’t generally attract much interest, maintaining adequate bowel motility is essential to avoid iatrogenic harm. The chapter on gastroparesis is located 👉 here. The chapter on ileus is located 👉 here. […]

  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 32
  • Next Page »

Login

 
 
Forgot Password

Feel Social?

  • Facebook
  • RSS
  • Twitter
  • YouTube
Metasin Coaching
RCM
SCRAM Bag

Other Stuff

  • Have a great idea for the next podcast? Share it here!
  • Tough Questions. Maybe you have an answer!
  • When you're done listening to the podcast,
    check out these great sites.

Who We Are

We are the EMCrit Project, a team of independent medical bloggers and podcasters joined together by our common love of cutting-edge care, iconoclastic ramblings, and FOAM.

EDECMO and RLA

Subscribe by Email

EMCrit is a trademark of Metasin LLC. Copyright 2009-. This site represents our opinions only. See our full disclaimer, our privacy policy, commenting policy and here for credits and attribution.